首页 › 慢性阻塞性肺病 › 内华达州 › Henderson
Henderson NV 慢性阻塞性肺病临床试验
4项针对 慢性阻塞性肺病的研究正在 Henderson及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
招募中2/3 期
- Henderson Clinical Trials, Henderson
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
招募中3 期
- Henderson Clinical Trials- Site Number : 8400026, Henderson
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
招募中3 期
- GSK Investigational Site, Henderson
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
招募中3 期
- GSK Investigational Site, Henderson
其他城市的 慢性阻塞性肺病试验
- Philadelphia, PA26 项研究
- Miami, FL20 项研究
- Houston, TX18 项研究
- Birmingham, AL17 项研究
- Baltimore, MD16 项研究
- Boston, MA15 项研究
- Orlando, FL15 项研究
- Chicago, IL15 项研究
- Dallas, TX13 项研究
- New York City, NY12 项研究
- Pittsburgh, PA11 项研究
- Winston-Salem, NC11 项研究
Henderson的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。